Literature DB >> 7141701

Intrathecal synthesis of virus antibodies in multiple sclerosis patients.

T Arnadottir, M Reunanen, A Salmi.   

Abstract

A follow-up study on the intrathecal synthesis of viral antibodies in multiple sclerosis patients was made on 28 patients over a period of about 2 years. Serial serum and cerebrospinal fluid specimens were assayed for antibodies against measles, rubella, parainfluenza type 2, respiratory syncytial, mumps, influenza A, influenza B, adeno, and herpes simplex viruses by employing a solid-phase enzyme immunoassay technique. All patients had local antibody synthesis against one or more of the antigens studied. Rubella and measles virus antibodies were found with the highest frequency and were synthesized at the highest rate. Simultaneous intrathecal antibody synthesis against the greater number of the viruses studied was associated with higher local immunoglobulin G synthesis. A good overall correspondence in the fluctuations of the different viral antibodies synthesized intrathecally was usually found. Sometimes the changes in intrathecal antibody levels correlated well with the changes in immunoglobulin G index and sometimes not. These fluctuations could not be correlated with the clinical course of the disease. The results of this study suggest that the viral antibodies studied are not relevant to the etiology or the pathogenesis of multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7141701      PMCID: PMC347752          DOI: 10.1128/iai.38.2.399-407.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  Computerized tomography in the diagnostic evaluation of multiple sclerosis.

Authors:  L A Hershey; M H Gado; J L Trotter
Journal:  Ann Neurol       Date:  1979-01       Impact factor: 10.422

3.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

Authors:  G Tibbling; H Link; S Ohman
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

4.  Immunoglobulin G and low molecular weight proteins in human cerebrospinal fluid. Chemical and immunological characterisation with special reference to multiple sclerosis.

Authors:  H Link
Journal:  Acta Neurol Scand       Date:  1967       Impact factor: 3.209

5.  Viral antibodies in multiple sclerosis.

Authors:  E Norrby
Journal:  Prog Med Virol       Date:  1978

6.  Antibodies against different viral antigens in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.

Authors:  A Salmi; M Panelius; R Vainionpää
Journal:  Acta Neurol Scand       Date:  1974       Impact factor: 3.209

7.  Measles virus antibodies in serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders, with special reference to measles antibody synthesis within the central nervous system.

Authors:  B Vandvik; M Degré
Journal:  J Neurol Sci       Date:  1975-02       Impact factor: 3.181

8.  Viral antibody activity of oligoclonal and polyclonal immunoglobulins synthesized within the central nervous system in multiple sclerosis.

Authors:  B Roström; H Link; M A Laurenzi; S Kam-Hansen; E Norrby; B Wahren
Journal:  Ann Neurol       Date:  1981-06       Impact factor: 10.422

9.  Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis.

Authors:  E Norrby; H Link; J E Olsson; M Panelius; A Salmi; B Vandvik
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

10.  Changes in immune response during responses in MS patients.

Authors:  R Detels; L W Myers; G W Ellison; B R Visscher; R M Malmgren; D L Madden; J L Sever
Journal:  Neurology       Date:  1981-04       Impact factor: 9.910

View more
  4 in total

1.  Soluble class I antigens in serum and CSF of patients with varicella-zoster virus meningitis.

Authors:  J Alvarez-Cermeño; J M Echevarría; L M Villar; I Lázaro; A Bootello; P González-Porque
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-10       Impact factor: 10.154

2.  In vivo and in vitro models of demyelinating disease. IX. Progression of JHM virus infection in the central nervous system of the rat during overt and asymptomatic phases.

Authors:  O Sorensen; M B Coulter-Mackie; S Puchalski; S Dales
Journal:  Virology       Date:  1984-09       Impact factor: 3.616

3.  Murine coronavirus-induced encephalomyelitis in rats: analysis of immunoglobulins and virus-specific antibodies in serum and cerebrospinal fluid.

Authors:  R Dörries; R Watanabe; H Wege; V ter Meulen
Journal:  J Neuroimmunol       Date:  1986-08       Impact factor: 3.478

4.  Analysis of the intrathecal humoral immune response in Brown Norway (BN) rats, infected with the murine coronavirus JHM.

Authors:  R Dörries; R Watanabe; H Wege; V ter Meulen
Journal:  J Neuroimmunol       Date:  1987-04       Impact factor: 3.478

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.